Brasil Pharma Upsizes Debenture

Brasil Pharma Upsizes Debenture

Brazil Bonds

Brasil Pharma has priced a BRL288m ($132m) domestic bond sale, according to regulatory documents, upsizing from a BRL250m base deal. The pharmacy operator tightened the yield on a BRL214m 2019 tranche to DI+1.70%, in from a DI+1.85% ceiling. A BRL74m

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial